dept header
Directory | Contact
 
How NYU Can Help

Established in September 2005, the Division of Thoracic Surgery at NYU Medical Center provides patients with up-to-the-minute surgical and non-surgical therapies for chest diseases. Through involvement in programs such as the International Early Lung Cancer Action Project (I-ELCAP) as well as by instituting a variety of clinical trials in all aspects of thoracic surgery, we strive to offer personalized, informative care with unique, effective treatment options. Moreover, with the addition of the New York Thoracic Surgery Laboratory at Bellevue, The Division of Throacic Surgery is investigating novel early detection markers as well as novel therapies for benign and malignant diseases of the chest.

Many Disciplines, One Goal

The NYU Thoracic Oncology Program uses a multidisciplinary approach to effectively diagnose and treat the problem. A team of professionals, including specialists in medical oncology, surgery, radiation therapy, pulmonary medicine, radiology and pathology collaborate to provide a balanced approach to solving a variety of thoracic problems.

We specialize in patients:

  • Interested in participating in a clinical trial

  • Under consideration for two or more concurrent therapies

  • Ineligible for surgical therapy due to limited pulmonary function

  • With abnormalities of the chest (benign or malignant, diagnosed or suspected, local or regional)

  • Who have undergone surgery for malignancies of the chest within six weeks of being seen at the NYU Cancer Center

Whether seeking a second opinion or ready to initiate treatment, we encourage patients diagnosed with a chest malignancy to see one of our specialists to compare medical opinions, learn the newest diagnostic and treatment options and make an informed decision.

Our Bench-to-Bedside Approach Improves Your Patient's Treatment Options

Research serves as an important part of our commitment to furthering patient care. We collaborate with other researchers to discover new diagnostic and treatment modalities to improve patient outcome. We are committed to state-of-the-art surgical management and developing novel treatment strategies using clinical trials. Through studies like these we make clinically relevant "bench-to-bedside" discoveries in early detection and develop targeted therapies.

We provide the newest in pioneering treatments, including:

  • early detection of airway malignancies with fluorescence bronchoscopy

  • novel diagnostic and staging modalities including endobronchial ultrasound

  • novel endobronchial treatment strategies including photodynamic therapy

  • investigation of non-surgical techniques selectively used for destruction of lung cancer nodules, including radiofrequency ablation and stereotactic radiation

  • use of stents to relieve blockages of the windpipe and esophagus

  • investigation of the use of replaceable stents in the windpipe and esophagus

Less Invasive Surgery, Less Post-Op Pain

Our minimally invasive surgery program incorporates video-assisted and "open chest" techniques along with new methods for post-operative pain relief. Procedures include:

  • video-assisted thoracoscopy for the chest

  • video-assisted laparoscopy for the abdomen

  • video-assisted procedures on benign lesions of the esophagus and lungs

  • minimally invasive esophagectomy and pulmonary resection

Every technique that we improve and each breakthrough we make help us accomplish our mission of compassionate, effective care.